stride trial semaglutide 📣Journal Club Alert📣 📅August 25th 2025📅 ⏰7 PM EST / 4 PM PST⏰ Topic: Trial: and walking capacity for symptomatic PAD and T2DM patients Presented by: Desiree Duncan & Michelle Semaglutide and walking capacity in

If youve got a recessed jaw, a narrow airway, a craniofacial issue, or a small posterior airway space, weight loss will help but it wont move your bones

Pelvic floor dysfunction, specifically dyssynergic defecation, occurs when the muscles that should relax during a bowel movement instead tighten

If youve been considering a structured and medically guided approach to weight management, now is the time to explore whether semaglutide is right for you

There will be 5 in-clinic visits and 7 phone calls Interventions: Drug: buntanetap/posiphen Drug: Placebo Primary Outcome Measures: Change From Baseline to Month 6 in MDS-UPDRS Part II (OFF-state) Change in the Score from the MDS- Unified Parkinson's Disease Rating Scale (UPDRS) Parts II from Baseline to the End of Trial

& Schoenbaum, G

These psychological benefits appeared early in treatment and persisted throughout the 48-week study period